Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ngmL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation

الملخص EN

Introduction.

Mucinous adenocarcinoma of the prostate is a rare variant of prostate cancer.

Its malignant potential and the clinical course of the affected patients remain, by and large, controversial.

No data exist about the course of metastatic mucinous adenocarcinoma of the prostate.

Case Presentation.

This case report describes the excellent clinical course of a 68-year-old patient with metastatic mucinous adenocarcinoma of the prostate, treated by radical prostatectomy, irradiation, and androgen deprivation.

Conclusion.

In our case, mucinous adenocarcinoma of the prostate does not appear to behave differently than acinar prostate cancer.

Its malignant potential is dependent on its Gleason score.